Structure of Theaflavin 3,3'-digallate
CAS No.: 30462-35-2
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Theaflavin 3,3'-digallate (TF-3) is an effective inhibitor of Zika virus (ZIKV) protease, with an IC50 of 2.3 μM. Theaflavin 3,3'-digallate directly binds to ZIKVpro (Kd=8.86 µM) and inhibits ZIKV replication. Theaflavin 3,3'-digallate inhibits the activity of gp41 and NS2B-3 proteases and exhibits antiviral activity against HSV and HIV-1. Theaflavin 3,3'-digallate is a typical pigment in black tea and an effective antitumor agent.
Synonyms: TF-3; ZP10; TFDG
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 30462-35-2 |
Formula : | C43H32O20 |
M.W : | 868.70 |
SMILES Code : | O=C(C1=CC(O)=C(O)C(O)=C1)O[C@H]2[C@H](OC3=CC(O)=CC(O)=C3C2)C4=C5C(C(C(O)=CC([C@@H]6[C@@H](CC7=C(O)C=C(O)C=C7O6)OC(C8=CC(O)=C(O)C(O)=C8)=O)=C5)=O)=C(O)C(O)=C4 |
Synonyms : |
TF-3; ZP10; TFDG
|
MDL No. : | MFCD06797365 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P280-P301+P312-P302+P352-P305+P351+P338 |
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
A549 cells | 75 µM | 1 hour | To evaluate the antiviral activity of theaflavins against HSV-1, results showed that TF3 at 50 μM and above inhibited >99% of HSV-1 viral particle production. | Antiviral Res. 2015 Jun;118:56-67 |
Vero cells | 75 µM | 1 hour | To evaluate the antiviral activity of theaflavins against HSV-1, results showed that TF3 at 50 μM and above inhibited >99% of HSV-1 viral particle production. | Antiviral Res. 2015 Jun;118:56-67 |
CV-1 cells | 250-500 µM | 1 hour | Assess the inactivation effect of TF-3 on HSV-1 clinical isolates. Results indicated that some HSV-1 clinical isolates required higher concentrations of TF-3 (250-500 μM) to achieve comparable inactivation to HSV-2. | Antimicrob Agents Chemother. 2013 Aug;57(8):3806-14 |
Vero cells | 100 µM | 1 hour | Evaluate the efficacy of TF-3 combined with lactic acid (LA) in inactivating HSV-1 and HSV-2 at various pH levels. Results showed that TF-3 combined with LA almost completely inactivated clinical isolates of HSV-2 and HSV-1 at pH 4.5 to 5.7. | Antimicrob Agents Chemother. 2013 Aug;57(8):3806-14 |
3T3-L1 adipocytes | 3.14 µM, 6.25 µM, 12.5 µM, 25 µM, 50 µM, 100 µM | 10 days (Day 18 to Day 28) | Theaflavin-3,3'-digallate (TF-3) reduced the impact of methylmercury by maintaining the adipocytes morphology and secretion patterns of adiponectin, resistin and 4-hydroxynonenal. TF-3 showed dose-dependent effects in counteracting methylmercury-induced oxidative stress and inflammation. | Int J Mol Sci. 2019 Jun 5;20(11):2755 |
H9c2 cells | 1-10 µM | 24 hours | Prevention of angiotensin II-induced pathological cardiac hypertrophy via inhibition of the CaN-NFAT signaling pathway | Nutrients. 2022 Mar 26;14(7):1391 |
Peritoneal macrophages | 40 µM | 24 hours | To evaluate the inhibitory effect of TFDG on NO production in LPS-activated macrophages. Results showed that TFDG downregulated NO production in a concentration-dependent manner, with maximal effect at 40 μM and no cytotoxicity observed. | Br J Pharmacol. 2006 Sep;149(1):121-31 |
Human ovarian carcinoma cells OVCAR-3 | 10-20 µM | 24 hours | TF3 significantly reduced the viability of OVCAR-3 cells and induced apoptosis and G0/G1 cell cycle arrest. | Molecules. 2019 Feb 14;24(4):673 |
Demineralized dentin collagen | 12.5, 25, 50, 100 mg/mL | 30 and 60 seconds | TF3/ethanol solution could effectively crosslink demineralized dentin collagen and improve its resistance to collagenase digestion and biomechanical properties (p<0.05), showing concentration and time dependence. The effect of 25 and 50 mg/ml TF3/ethanol solution was similar to that of 5% GA, whereas the 100 mg/mL TF3/ethanol solution exhibited better performance (p<0.05). | Front Bioeng Biotechnol. 2024 May 15;12:1401032 |
Rat aortic rings | 0.02–2 µM | 30 minutes | To investigate the vasorelaxation induced by theaflavin-3,3'-digallate and its mechanism, it was found that it mediates NO-dependent vasodilation through the production of hydrogen peroxide (H2O2). | Antioxidants (Basel). 2020 May 7;9(5):390 |
Rat aortic endothelial cells (RAECs) | 0.5 μg/mL | 30 minutes | TF3 suppressed Hcy-induced ER stress markers (e.g., phosphorylated eIF2α, ATF3, and cleaved ATF6) and reduced ROS production. | Sci Rep. 2015 May 15;5:10340 |
Rat aortic smooth muscle cells (RASMCs) | 1, 10, 20 µM | 48 hours | To evaluate the effect of TF3 on PDGF-BB-induced migration in RASMCs. Wound healing and Transwell assays showed that TF3 inhibited PDGF-BB-induced migration in a concentration-dependent manner. | Front Pharmacol. 2022 Jul 12;13:861319 |
Rat aortic smooth muscle cells (RASMCs) | 1, 10, 20 µM | 48 hours | To evaluate the effect of TF3 on PDGF-BB-induced proliferation in RASMCs. EdU and CCK-8 assays showed that TF3 inhibited PDGF-BB-induced proliferation in a concentration-dependent manner. | Front Pharmacol. 2022 Jul 12;13:861319 |
Rat aortic smooth muscle cells (RASMCs) | 1, 10, 20 µM | 48 hours | To evaluate the effect of TF3 on PDGF-BB-induced phenotypic switching in RASMCs. Results showed that TF3 reversed the PDGF-BB-induced decrease in contractile proteins (MYH11, α-SMA, and SM22) in a concentration-dependent manner. | Front Pharmacol. 2022 Jul 12;13:861319 |
Purified F1-ATPase | 0.7 µM | 5 minutes | To evaluate the inhibitory effect of Theaflavin 3,3'-digallate on purified F1-ATPase, results showed an IC50 value of 0.7 μM and an inhibition rate of 90%. | J Nutr Biochem. 2012 Aug;23(8):953-60 |
E. coli membrane vesicles | 10-20 µM | 5 minutes | To evaluate the inhibitory effect of Theaflavin 3,3'-digallate on ATP hydrolysis, results showed an IC50 value of 10 μM and an inhibition rate of 90%. | J Nutr Biochem. 2012 Aug;23(8):953-60 |
MC3T3-E1 cells | 0.1 µM and 1 µM | 7 days | TFDG promotes the formation of osteoblasts and enhances their mineralization ability in inflammatory environment | Front Pharmacol. 2021 Mar 23;12:648969 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Zebrafish (Danio rerio) | Alloxan-induced diabetic model | Water solution treatment | 0.5-20 μg/mL | 24 hours | To evaluate the hypoglycemic effect and mechanism of TF3 in diabetic zebrafish, results showed that TF3 could significantly reduce blood glucose levels by down-regulating PEPCK and up-regulating GCK expression, and promote β cells regeneration at low concentrations. | Nutrients. 2021 Dec 7;13(12):4379 |
C57BL/6 mice | Ovariectomy-induced osteoporosis model | Injection | 1 mg/kg and 10 mg/kg | Every 2 days for 5 weeks | TFDG significantly increased bone mass in ovariectomized mice, reduced the release of proinflammatory cytokines, and increased the expression of osteogenic markers | Front Pharmacol. 2021 Mar 23;12:648969 |
DBA/1 mice | Collagen-induced arthritis (CIA) model | Intraperitoneal injection | 1 mg/kg or 10 mg/kg | 6 days a week for 8 weeks | To investigate the effect of TFDG on CIA mice. Results showed that TFDG ameliorated joint destruction, reduced inflammatory cytokines, and promoted M2 macrophage polarization. | J Inflamm Res. 2023 Jan 10;16:109-126 |
C57BL/6J female mice | Ovariectomy (OVX)-induced osteoporosis model | Intraperitoneal injection | 1 mg/kg, 10 mg/kg | Three times per week for 3 months | To evaluate the effect of TF3 on OVX-induced bone loss. Results showed that TF3 significantly attenuated OVX-induced bone loss and osteoclastogenesis in a dose-dependent manner. | Front Pharmacol. 2020 Jun 29;11:803 |
C57BL/6 mice | Carotid artery ligation model | Intraperitoneal injection | 10 mg/kg | Injected one day before surgery and repeated every other day for 14 or 28 days | To evaluate the effect of TF3 on carotid artery ligation-induced neointimal hyperplasia. Results showed that TF3 significantly reduced the intima-to-media ratio (I/M ratio) and increased lumen diameter and area. | Front Pharmacol. 2022 Jul 12;13:861319 |
Chicken embryos | Chick chorioallantoic membrane (CAM) model | Implanted onto the CAM | 25 µM | Single administration, lasting for 5 days | To evaluate the inhibitory effect of TF3 on tumor angiogenesis in vivo, results showed that TF3 significantly reduced blood vessel density. | Int J Oncol. 2016 Jan;48(1):281-92 |
Mice | Leptin-deficient obese (ob/ob) mice | Intraperitoneal injection | 5 mg/kg, 10 mg/kg, 20 mg/kg | Once daily for 4 weeks | TF3 treatment prevented body weight and waistline gain, reduced lipid accumulation, and alleviated liver function injury, as well as decreased serum lipid levels and TG levels in livers. | Front Pharmacol. 2022 Aug 29;13:925264 |
BALB/c mice | TNBS-induced colitis model | Oral gavage | 5 mg/kg/day | Once daily for 18 days | To evaluate the protective effect of TFDG on TNBS-induced colitis. Results showed that TFDG significantly improved macroscopic and microscopic damage scores, reduced neutrophil infiltration, decreased mRNA and protein levels of proinflammatory cytokines (TNF-α, IL-12, IFN-γ) and iNOS, and preserved IκBα by inhibiting IKK activity and nuclear translocation of NF-κB. | Br J Pharmacol. 2006 Sep;149(1):121-31 |
BALB/c mice | S aureus pneumonia model | Hypodermic injection | 50 mg/kg TFDG, 15 mg/kg cephalothin | Every 12 hours for 72 hours | Evaluate the protective effect of TFDG combined with cephalothin against S aureus pneumonia in mice, showing that the combination significantly reduced mortality and alleviated lung pathological changes. | J Cell Mol Med. 2019 Oct;23(10):6955-6964 |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.15mL 0.23mL 0.12mL |
5.76mL 1.15mL 0.58mL |
11.51mL 2.30mL 1.15mL |
Tags: Theaflavin 3,3'-digallate | TF-3 | ZP10 | TF3 | TF 3 | ZP10 | ZP 10 | ZP-10 | Virus Protease | HSV | HIV | Flavivirus | Herpes simplex virus | Human immunodeficiency virus | ZIKV | replication | translation | p53 | p21 | Akt | MAPK | NF-κB | ERK1/2 | -MEK1/2 | NS3 | U87 | gp41 | NS2B-3 | inhibitor | 30462-35-2 |
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL